GlassScriptPhysician profile
Chitra Kodery
NPI 1538422993
$1,342.72
in general payments reported to CMS, 2019-2025
20 companies · $782 in 2025
The $782 reported for 2025 was more than what 81% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13.33 · 2020: $13.36 · 2024: $534 · 2025: $782.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,316.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,316.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spinal Simplicity, LLC | $198.38 | 2025 | Ha Minuteman G3-R |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $191.94 | 2024-2025 | Relistor |
| Abbott Laboratories | $144.40 | 2025 | Proclaim |
| Medtronic, INC. | $137.74 | 2024 | Intellis Adaptivestim |
| Nalu Medical, INC. | $124.98 | 2024 | Nalu Neurostimulation System |
| Scilex Pharmaceuticals INC. | $95.99 | 2024-2025 | |
| Collegium Pharmaceutical, INC. | $85.49 | 2024-2025 | Xtampza, Belbuca |
| Trice Medical, INC. | $75.81 | 2025 | |
| Foundation Fusion Solutions, LLC | $56.66 | 2024-2025 | |
| Forte Bio-Pharma LLC | $50.07 | 2025 | Prolate, Tanlor, Nalocet |
| Biotronik Nro, INC. | $26.51 | 2025 | Prospera |
| Pfizer INC. | $21.22 | 2024 | |
| Valinor Pharma, LLC | $19.94 | 2025 | Movantik |
| Alkermes, INC. | $18.16 | 2025 | Vivitrol |
| Globus Medical, INC. | $17.92 | 2025 | Senza |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $17.25 | 2024 | |
| Protega Pharmaceutials INC | $17.19 | 2025 | Roxybond |
| Vertex Pharmaceuticals Incorporated | $16.38 | 2025 | |
| Dynavax Technologies Corporation | $13.36 | 2020 | |
| Otsuka America Pharmaceutical, INC. | $13.33 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chitra Kodery listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.